Use of hmgcoa reductase inhibitors in the prevention of diseases whose pathogenesis is dependent on neovascularization
A Standard patent application filed on 05 May 2000 credited to Galper, Jonas B. ; Kong, Dequan ; Iruela-Arispe, Luisa

Details

Application number :

49881  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Use of hmgcoa reductase inhibitors in the prevention of diseases whose pathogenesis is dependent on neovascularization  

Inventor :

Galper, Jonas B. ; Kong, Dequan ; Iruela-Arispe, Luisa  

Agent name :

 

Address for service :

 

Filing date :

05 May 2000  

Associated companies :

 

Applicant name :

Brigham and Women's Hospital  

Applicant address :

 

Old name :

 

Original Source :

Go